The attorneys at Montgomery & Ponder, LLC are investigating cases related to textured breast implants made by Allergan. The FDA took action on July 24, 2019 by requesting that Allergan recall specific models of its textured breast implants from the U.S. market. This comes after 573 unique cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and 33 patient deaths as a result of textured and smooth breast implants and tissue expanders. Of these 573 cases, 481 have been attributed to Allergan implants. And 12 of the 13 deaths where the implant manufacturer is known are confirmed to have had an Allergan implant at the time of their BIA-ALCL diagnosis.
The New York Times reported “[t]he disease is anaplastic large-cell lymphoma, a rare cancer of the immune system. It is not breast cancer, but develops in tissue around the implant. In most cases, removing the implant and the scar tissue around it cures the cancer, but if it is not detected early it can spread and kill the patient.” For years, women who have been treated for for implant related lymphoma have been advocating for a ban of these implants, and the FDA finally took action. “The main symptoms of the lymphoma are usually swelling and fluid accumulation around the implant. If these symptoms occur, the fluid should be drained and tested for the cancer.” The FDA issued a safety communication on the day it issued the ban, informing patients to monitor for symptoms of BIA-ALCL, including pain and swelling in their breasts. If you are experiencing these symptoms and have received one of the breast implants listed below, you are advised to visit your doctor immediately.
List of Recalled Implants
- Natrelle saline-filled breast implants
- Natrelle silicone-filled breast implants
- Natrelle Inspira silicone-filled breast implants
- Natrelle 410 highly cohesive anatomically shaped silicone-filled breast implants